01 1VERTEX PHARMS
02 22VERTEX PHARMS INC
01 2311564916
01 23Blank
01 23Blank
01 232029-08-13
Patent Expiration Date : 2029-08-13
US Patent Number : 11564916
Drug Substance Claim :
Drug Product Claim :
Application Number : 207925
Patent Use Code : U-3528
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-08-13
Patent Expiration Date : 2029-08-13
IVACAFTOR; IVACAFTOR, TEZACAFTOR
US Patent Number : 11564916
Drug Substance Claim :
Drug Product Claim :
Application Number : 210491
Patent Use Code : U-3527
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-08-13
Patent Expiration Date : 2029-08-13
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 11564916
Drug Substance Claim :
Drug Product Claim :
Application Number : 212273
Patent Use Code : U-4063
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-08-13
Patent Expiration Date : 2029-08-13
US Patent Number : 11564916
Drug Substance Claim :
Drug Product Claim :
Application Number : 206038
Patent Use Code : U-3529
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-08-13
Patent Expiration Date : 2029-08-13
DEUTIVACAFTOR; TEZACAFTOR; VANZACAFTOR CALCIUM
US Patent Number : 11564916
Drug Substance Claim :
Drug Product Claim :
Application Number : 218730
Patent Use Code : U-4095
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-08-13
Patent Expiration Date : 2029-08-13
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 11564916
Drug Substance Claim :
Drug Product Claim :
Application Number : 217660
Patent Use Code : U-4055
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-08-13
Patent Expiration Date : 2029-08-13
US Patent Number : 11564916
Drug Substance Claim :
Drug Product Claim :
Application Number : 207925
Patent Use Code : U-3603
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-08-13
Patent Expiration Date : 2029-08-13
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 11564916
Drug Substance Claim :
Drug Product Claim :
Application Number : 217660
Patent Use Code : U-3585
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-08-13
Patent Expiration Date : 2029-08-13
US Patent Number : 11564916
Drug Substance Claim :
Drug Product Claim :
Application Number : 211358
Patent Use Code : U-3526
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-08-13
Patent Expiration Date : 2029-08-13
IVACAFTOR; IVACAFTOR, TEZACAFTOR
US Patent Number : 11564916
Drug Substance Claim :
Drug Product Claim :
Application Number : 210491
Patent Use Code : U-3527
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-08-13
